| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/30/1997 | EP0785935A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
| 07/30/1997 | EP0785930A1 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b 4? (ltb 4?) antagonists |
| 07/30/1997 | EP0785802A1 Saponin preparations and use thereof in iscoms |
| 07/30/1997 | EP0785789A1 Diazepino-indoles as phosphodiesterase iv inhibitors |
| 07/30/1997 | EP0785786A1 Microbial synthesis of hiv protease inhibitors |
| 07/30/1997 | EP0785784A1 4-heterocyclic piperidines promote release of growth hormone |
| 07/30/1997 | EP0785781A2 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 07/30/1997 | EP0668866B1 Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155838A Indolinone compounds for the treatment of disease |
| 07/30/1997 | CN1155418A Use of novel steroid esters for preparing medicaments flammatory and anti-allergic activity |
| 07/29/1997 | US5652262 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 07/29/1997 | US5652250 N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives and process for their preparation |
| 07/29/1997 | US5652246 Neurokinin receptor antagonists; nervous system disorders |
| 07/29/1997 | US5652243 Modulating cellular response |
| 07/29/1997 | US5652219 Hemoregulatory peptides |
| 07/29/1997 | US5652124 α-glycosyl hesperidin, and its preparation and uses |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5651993 Irradiating leukocyte mixture in psoralen presence; reacting with peptide antigens |
| 07/29/1997 | US5651980 Methods of use of uncoated gel particles |
| 07/29/1997 | US5651968 Methods and compositions for attenuating antibody-mediated xenograft rejection in human recipients |
| 07/29/1997 | CA1339147C Salt-type compounds, pharmaceutical compositions containing them and process for preparing same |
| 07/29/1997 | CA1339128C Compounds |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/24/1997 | WO1997026535A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026279A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026278A1 Synthetic il-10 analogues |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026257A1 Hydroxamic acid based collagenase inhibitors |
| 07/24/1997 | WO1997026237A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | WO1997025981A1 Medical use |
| 07/24/1997 | WO1997025977A1 Pharmaceutical compositions |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | WO1997017072A3 Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system |
| 07/24/1997 | WO1997007198A3 Dna sequences and secreted proteins encoded thereby |
| 07/24/1997 | CA2678707A1 Pharmaceutical compositions comprising ascomycin derivatives |
| 07/24/1997 | CA2243295A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions |
| 07/24/1997 | CA2243275A1 Synthetic il-10 analogues |
| 07/24/1997 | CA2242913A1 Hydroxamic acid based collagenase inhibitors |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/24/1997 | CA2215900A1 Leptospiral outer membrane proteins |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785270A1 Staphylococcus aureus Seryl-tRNA synthetase |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785268A1 Staphylococcus aureus methionyl-tRNA synthetase |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785260A1 Alanyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785259A1 Asparaginyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0785257A1 Cysteinyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785256A1 Staphylococcus aureus glycyl-tRNA synthetase |
| 07/23/1997 | EP0785190A2 Quinolinone derivative and antiallergic agent with said quinolinone derivative as the active ingredient |
| 07/23/1997 | EP0784976A1 Immunosuppressive-activity potentiating compositions containing ascorbyl tocopheryl phosphoric acid diesters |
| 07/23/1997 | EP0784692A1 Attenuated viruses and method of making the same |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784676A1 Neutralization of foof allergens by thioredoxin |
| 07/23/1997 | EP0784629A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 07/23/1997 | EP0784628A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 07/23/1997 | EP0784624A1 Purine and guanine compounds as inhibitors of pnp |
| 07/23/1997 | EP0784623A1 Naphthyridine derivatives |
| 07/23/1997 | EP0784622A1 Naphthyridinone derivatives |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0784482A2 Methods for inhibiting antigen specific t cell responses |
| 07/23/1997 | EP0784479A1 Inhibition of human rotavirus infection |
| 07/23/1997 | EP0784478A1 Inhibition of endothelin-1 to reduce inflammatory processes |
| 07/23/1997 | EP0784477A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 07/23/1997 | EP0784476A1 Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b 12? compound |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0586617B1 Anti-CD3 aglycosylated IgG Antibody |
| 07/23/1997 | EP0532530B1 Derivatives of 6-aminooctahydroindolizinetriol |
| 07/23/1997 | CN1155245A Use of muramyl peptide compounds |
| 07/22/1997 | US5650538 Organic salts of N,N'-diacetyl cystine |
| 07/22/1997 | US5650494 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/22/1997 | US5650492 P-40 homodimer of interleukin-12 |
| 07/22/1997 | US5650487 Blood disorders |
| 07/22/1997 | US5650444 Bronchodilator agents, antiallergens and antiinflammatory agents |